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T
he microtubule cytoskeleton not 
only gives cells their shape but 
also sets up and maintains cell 
polarity. For example, microtubule-
based motors help establish polarity by 
delivering certain cargoes to specific 
sites, and microtubule plus end–tracking 
proteins (+TIPs) help guide the growth 
and connection of microtubules to the 
cell cortex and other cellular structures. 
Anna Akhmanova is intent on working 
out how +TIPs interact with microtubules 
and with each other (1–3) and how motor 
proteins bind their cargoes (4, 5), with 
the aim of better understanding how cell 
polarity is generated.
Born and raised in Moscow in a family 
of scientists, Akhmanova says she was in-
terested in nature even as a child, so her 
decision to pursue a research career was 
a natural one. Things have continued to 
progress since then, and we reached her at 
her new laboratory at Utrecht University to 
talk about how she’s building her career.
PROMISING START
What made you decide to pursue a 
career in research?
All of my family are scientists. My grand-
mother was a professor in English and lin-
guistics, and my father was a 
professor in physics. Both 
my mother and brother hold 
PhDs in physics. So, I was 
surrounded by scientists 
from my early childhood, 
and a career in science was a 
very natural choice for me.
What did you focus on in 
school?
I went to school at Moscow State Uni-
versity, where I studied biology. At that 
time, higher education in Russia was not 
divided into bachelor’s and master’s de-
grees like it is in Western universities. 
There was just a single, fi  ve-year-long 
program, and at the end of it you received 
your master’s degree.
For the fi  rst two years we studied all 
the major biology subjects, like botany 
and zoology, but also biochemistry, mo-
lecular biology, and cell biology. Then, 
like everyone else, my fifth year was 
dedicated to doing a big research project. 
I studied halophilic archaebacteria in 
Alexander Mankin’s laboratory. I learned 
most of the molecular biology I know 
from him.
RESTRUCTURING
Why did you decide to leave Russia to 
pursue your PhD?
When I fi  nished my master’s in 1989, 
things in Russia were changing drastically; 
this was during the time of perestroika. 
Before perestroika, the university and 
research system in Russia was doing 
okay. But then, in a very short period of 
time, it pretty much dissolved, so a lot 
of people went to work abroad. I tried to 
become a PhD student in Russia, but the 
salaries were very low, there was abso-
lutely no funding to do research, and the 
country as a whole was experiencing 
problems that were far more serious. 
So, when I got an opportunity to go to 
the Netherlands, I decided to go there to 
do my PhD.
Was that a difﬁ  cult 
transition for you?
It was diffi  cult. I had a very 
small child at that time, and 
I was trying to do my PhD 
and adapt to a foreign coun-
try. But I think that when 
you’re young these types of 
transitions are easier. I do 
not think I would be able to 
cope with that kind of challenge now, but 
at the time it was okay, and it was all very 
worthwhile. My daughter is a real driving 
force in my life outside of the lab.
Scientifi  cally, at that time, I was inter-
ested in gene regulation, so I joined Wolf-
gang Hennig’s lab at the University of 
Nijmegen and tried to obtain mutants of 
different histone genes. For various rea-
sons, the project did not go very well, so, 
although these years were very formative 
for me, maybe they were less good in 
terms of having scientifi  c success.
But you kept on…
I actually did two postdocs. For the fi  rst 
one I stayed on at the University of Nij-
megen and worked on several anaerobic 
organisms in the Department of Micro-
biology. For my second postdoc, I went 
to the Erasmus University of Rotterdam, 
to the Department of Cell Biology led 
by Frank Grosveld, because I wanted to 
work on transcription and gene regula-
tion again. I joined Niels Galjart’s lab to 
work on a particular transcription factor, 
and for part of that project I had to per-
form a yeast two-hybrid screen with that 
protein. While I was setting that up, the 
other person in the lab, Casper Hoogen-
raad, asked me if I would help him screen 
a protein that he was working on, a micro-
tubule-binding protein called CLIP-115. 
I did, and we picked up some clones: one 
of them was a very poorly studied pro-
tein, which we called CLASP, for CLIP-
associating protein. The other was a 
homologue of a well-studied fl  y protein 
called Bicaudal-D. These two hits de-
fi  ned my career.
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Akhmanova studies microtubule plus end–binding proteins and proteins 
that interact with microtubule motors.
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“CLASPs have 
the capacity 
to make the 
microtubule 
system 
asymmetric.”
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WELL ESTABLISHED
What did CLASP turn out to do?
We now know that CLASPs are a family of 
proteins that can bind to microtubules di-
rectly but that also can interact with the 
microtubule plus end–binding protein EB1. 
Probably both interactions are important to 
allow CLASPs to bind microtubules and to 
allow CLASPs to become enriched at the 
growing microtubule plus end, where they 
may help stabilize microtubules. But 
CLASPs also have a domain that binds 
other proteins, including one called LL5b, 
which is a lipid-binding protein found at 
the plasma membrane and predominantly 
localized at a cell’s leading edge.
The reason why we originally be-
came interested in CLASPs is because, 
unlike many other microtubule-binding 
proteins, CLASPs are preferentially en-
riched at the leading edge of migrating 
cells. That is partly due to interactions 
with LL5b but also because CLASPs 
are strongly regulated by a kinase called 
GSK-3. GSK-3 is present throughout 
the cell, and, when active, it suppresses 
the binding of CLASPs to microtubules. 
However, this kinase is inactive at the 
leading edge, so CLASPs bind best to 
microtubule plus ends at the leading 
edge. In this way, CLASPs have the ca-
pacity to make the microtubule system 
asymmetric. This is important for cel-
lular polarity and phenomena that de-
pend on it, such as cell migration and 
polarized secretion.
What about the other hit in your screen?
When we fi  rst found Bicaudal-D, we were 
just really curious what the protein was 
doing, and that led us into studying how 
motors attach to different cargo. We’ve 
been studying cytoplasmic dynein, which 
is a very large, ubiquitous, minus end–
directed microtubule-based motor. For 
quite a few years we’ve been trying to 
understand how Bicaudal-D binds to dy-
nein and how it attaches to its vesicular 
cargo. We’ve found that Bicaudal-D 
binds to dynein via its N-terminal region 
and binds to the small GTPase Rab6 via 
its C-terminal region. Rab6 binds to the 
vesicular membrane, completing the bridge 
between dynein and its cargo vesicles.
Bicaudal-D is an interesting mole-
cule because, if you just put it into cells, 
it actually doesn’t do much. 
However, if you take the 
N-terminal part of the mol-
ecule and attach it to al-
most any cargo, it induces 
very rapid and effi  cient 
transport by cytoplasmic 
dynein. Also, the C-terminal 
part acts as a dominant-
negative for Bicaudal-D 
function: it not only blocks 
binding of the wild-type 
protein to Rab6-positive 
cargo vesicles but also 
blocks Bicaudal-D binding to the nuclear 
envelope during the G2 phase of the cell 
cycle, where it normally helps to posi-
tion the nucleus and centrosomes relative 
to each other.
We think that Bicaudal-D as a whole is 
self-inhibited—it adopts a folded confor-
mation that prevents it from interacting with 
other proteins. Bicaudal-D is not the only 
microtubule-interacting 
protein that behaves this 
way; a couple of years back 
we published a paper about 
a micro  tubule plus end–
binding protein, CLIP-170, 
that is also self-inhibited. 
I’m interested in how these 
types of molecules are 
self-inhibited and how 
they’re activated.
Where is this work 
taking you now?
I’m collaborating quite 
strongly with Casper’s lab-
oratory, and in January we 
both moved our labs to Utrecht University, 
where we are running the Division of Cell 
Biology together. I am happy because our 
labs are now right next door to each other, 
and we can preserve our collaboration.
I’ve also recently become very inter-
ested in structural studies. That’s partly 
because a couple years back I started to 
collaborate very intensively with Michel 
Steinmetz’s lab in Switzerland on the 
structure of +TIP complexes. I think that 
in the future it will be important to un-
derstand what Bicaudal-D’s interactions 
with other proteins look 
like at the molecular level: 
what the structure is and 
how the structure translates 
into function.
We are also working to 
identify more microtubule 
plus end–binding proteins, 
particularly proteins that 
interact with EB1 and its rela-
tives EB2 and EB3. What 
we’re currently discovering 
is that the diversity of the 
plus end–binding proteins 
is much bigger than we previously thought. 
It will be exciting to get our hands on this 
whole zoo of proteins.
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Microtubule plus end–binding proteins 
(green) decorate the growing ends of 
microtubules (red).
“The diversity 
of the plus 
end–binding 
proteins is 
much bigger 
than we 
previously 
thought.”
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Akhmanova’s daughter (right) orchestrates a zipline mother–
daughter adventure.